GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC-CFI-0001940/2026

Establishment Labs S.A. v. GC Aesthetics ParentCo Limited Nagor Limited GC Aesthetics Management Limited GC Aesthetics (Distribution) Limited GC Aesthetics (France) SAS EuroSilicone SAS GC Aesthetics Italy S.R.L. GC Aesthetics GmbH GC Aesthetics Spain, S.L.U. GC Aesthetics GmbH GC Aesthetics Holdings Limited GC Aesthetics Finance Limited Romed NV

Datum
2026-06-08
Kammer
Brussels (BE) Local Division
Verfahrensart
Counterclaim for revocation
Sprache
EN

Metadaten

Fall-IDUPC-CFI-0001940-2026-a5254a96b43a
AktenzeichenUPC-CFI-0001940/2026
RegisterzeichenUPC-CFI-0001940/2026
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 3

Brussels - Local Division UPC_CFI_029/2026 UPC_CFI_1934/2026 UPC_CFI_1940/2026 Procedural Order (R.37 RoP) (I) of the Court of First Instance of the Unified Patent Court Issued on 8 June 2026 Concerning EP 3 689 383 CLAIMANT 2SEVENTY BIO, INC. Represented by: Mr. Thomas Wolter Mr. Eliot Ward Mr. Matthew Naylor All above representatives with the following address : Mewburn Ellis LLP, 8 Bishopsgate London, EC2N 4BQ, United Kingdom Additional Representatives: Mrs. Amy Crouch, Mrs. Camilla Balleny, Mr. Sean Jauss, Mr. Alex Galbraith, Mrs. Anja Koller, Mr. Lauren Woolley and Mr. Liam Batty Electronic address for servicing: Mewburn-BMS-BCMA@mewburn.com Hereafter referred to as: Claimant or Applicant DEFENDANTS (1) JOHNSON & JOHNSON (**) (2) JANSSEN BIOTECH, INC. (*) (3) JANSSEN PHARMACEUTICALS I ...